%0 Journal Article
%T Prolonged fever after Infliximab infusion
%A Jennifer Katz
%A Michael Frank
%J World Journal of Gastrointestinal Pharmacology and Therapeutics
%D 2012
%I Baishideng Publishing Group Co. Limited
%R 10.4292/wjgpt.v3.i3.34
%X Pharmacologic management for ulcerative colitis (UC) has recently been expanded to include anti- tumor necrosis factor (TNF) therapy for severe disease. Infliximab, a chimeric monoclonal antibody directed again TNF ¦Á was first tested in patients with Crohn¡¯s disease. In addition to serious infections, malignancy, drug induced lupus and other autoimmune diseases, serum sickness-like reactions, neurological disease, and infusion reactions further complicate the use of Infliximab. We report a case of prolonged fever after Infliximab infusion to treat steroid refractory UC.
%K Infliximab
%K Fever
%K Ulcerative colitis
%K Crohn¡¯s disease
%U http://www.wjgnet.com/2150-5349/full/v3/i3/34.htm